The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Stuart J. Turner, MPH
Advertisement
Articles by Stuart J. Turner, MPH
Advertisement
Latest Updated Articles
- Pharmacotherapy Timing in Heart Failure and Impact on Healthcare Costs
Published: November 16th 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
2
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
3
A Common Virus May Hold New Clues to Lupus
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5
